Medindia

X

Elsevier is Expanding eClinical Solutions in Europe

Saturday, November 1, 2008 General News J E 4
Advertisement
COPENHAGEN, Denmark, October 31

- DoctorConsult in Germany Marks First of Several Localized WorkflowSolutions That Improve Clinician Decision Making and Health Care BusinessPerformance

With a deep understanding of healthcare workflow and more than a centuryof experience as a global medical publisher, Elsevier is increasing itsefforts to provide interactive clinical reference and clinical decisionsupport (CDS) tools to new markets in Europe. With the launch ofDoctorConsult - the German language version of MD Consult (http://www.doctorconsult.de) -- Elsevier becomes the first multi-lingualprofessional clinical reference product provider.

The customized products meet the cultural needs of users who do not speakEnglish as a first language, and address specific medical practice needswithin different countries. The internet-based products provide users with afull range of medical information covering a variety of clinical needs. Inone integrated interface, users can access evidence-based immediatelyactionable 'quick answers' (i.e. Elsevier's FirstConsult) as well asbackground references such as books and full text journal articles suitablefor more in depth research and education needs. Additional localized versionsof MD Consult are in development for Italy, France and Spain.

The Consult suite of multilingual reference products is just one ofseveral solutions being developed to meet local reference, point-of-care,workflow and decision support needs. Additional solutions in developmentinclude:

"Elsevier has been transforming CDS technology to offer a higher level ofusability, primarily in the U.S. and now more so in Europe," said JoseWehnes, Managing Director of the International Division of Elsevier HealthSciences. "Elsevier knowledge solutions, from drug information and actionabledecision support, to process improvement and predictive analysis, have thepotential to help deliver timely and appropriate information to clinicians inany country as they make critical diagnostic and therapeutic decisionsthroughout their workday."

Capturing 'e' Opportunities

Elsevier is uniquely positioned to replicate its success in the U.S.abroad. Market dynamics are different, as European E-Health markets andElsevier's positions within them are at an earlier stage of development thanin the U.S. However, key underlying market forces are similar to those in theU.S, particularly the drive to contain costs and improve outcomes, and therapid increase in internet usage by physicians and other healthcarepractitioners.

"By building upon our core strengths in leading content to provideinformation and workflow solutions, we can improve outcomes and efficienciesfor both payers and providers on a country by country basis," said Wehnes."Growing Elsevier Clinical Decision Support in Europe reinforces Elsevier'sbroader business strategy to strengthen its lead in core content, drive thetransition of print materials to e-formats and deliver solutions directlyinto the clinical process."

Come by booth #625 at the World of Health IT Conference in Copenhagen,Denmark November 4-6, 2008 to learn more.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical andmedical information products and services. Working in partnership with theglobal science and health communities, Elsevier's 7,000 employees in over 70offices worldwide publish more than 2,000 journals and 1,900 new books peryear, in addition to offering a suite of innovative electronic products, suchas ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Mosby Nursing Consult (http://www.nursingconsult.com) Scopus (http://www.info.scopus.com/),bibliographic databases and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered inAmsterdam, The Netherlands and has offices worldwide. Elsevier is part ofReed Elsevier Group plc (http://www.reedelsevier.com/), a world-leadingpublisher and information provider. Operating in the science and medical,legal, education and business-to-business sectors, Reed Elsevier provideshigh-quality and flexible information solutions to users, with increasingemphasis on the Internet as a means of delivery. Reed Elsevier's tickersymbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK andENL (New York Stock Exchange).- Clinical Decision Support: - Guidelines and best practice information delivered when and where they are most useful at the point of care - Leveraging of patient data to pinpoint the most needed information for a given clinical task - Drug information and safety checking, also linked to patient data when possible - Seamless content integration with Electronic Health Records, including infobuttons and alerts - Payer services: - Retrospective analytics for identifying performance gaps and outliers - Tools to influence provider behavior (CDS solutions)

SOURCE Elsevier
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Torchmark Corporation Declares Dividend
S
Cephalon Receives FDA Approval for TREANDA to Trea...